Reply to the letter 'Digoxin in patients with atrial fibrillation and heart failure: A risk factor or a marker of increased mortality'

MLA

Chirag Bavishi, et al. “Reply to the Letter ‘Digoxin in Patients with Atrial Fibrillation and Heart Failure: A Risk Factor or a Marker of Increased Mortality.’” International Journal of Cardiology, vol. 206, Dec. 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....95f14139c6e2176a4d0b76eb7e558070&authtype=sso&custid=ns315887.

APA

Chirag Bavishi, Sameer Ather, & Abdur Rahman Khan. (2015). Reply to the letter “Digoxin in patients with atrial fibrillation and heart failure: A risk factor or a marker of increased mortality.” International Journal of Cardiology, 206.

Chicago

Chirag Bavishi, Sameer Ather, and Abdur Rahman Khan. 2015. “Reply to the Letter ‘Digoxin in Patients with Atrial Fibrillation and Heart Failure: A Risk Factor or a Marker of Increased Mortality.’” International Journal of Cardiology 206 (December). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....95f14139c6e2176a4d0b76eb7e558070&authtype=sso&custid=ns315887.